ALC · NYSE · STOCK
Alcon (ALC) Stock Analysis
$64.11
52W $61.84 – $87.64
56/100
$31.27B
49.3
0.73
Is ALC Bullish or Bearish?
Mixed.
Innellis AI committee rates Alcon Inc (ALC) Watch with a composite score of 56/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +4.01 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -15.99 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.24) -- balance sheet can absorb a shock. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.24) -- balance sheet can absorb a shock — Risk
Bear Case
- P/E of 38.3 is moderate-to-rich — Value
- ROE of only 2.9% -- cheap may mean cheap for a reason — Value
- EPS declining -39.5% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Price structure making lower highs and lower lows — Technical
- Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
56/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 59%
of 192 Healthcare peers
Value Analyst
neutral
49
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 38.3 is moderate-to-rich
Growth Analyst
bearish
32
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -39.5% YoY despite any revenue growth
Technical Analyst
neutral
53
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.24) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 54.0 to 56.0.
- New bearish signals: 1 appeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 3 signal(s) disappeared.
Analyst-level changes:
- Technical Analyst: score 41->53 (+12); +1 bullish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
45.0
Neutral
MACD Histogram
0.062
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$63.82
Resistance
$76.15
Bollinger %B
0.35
Inside Bands
Price vs Moving Averages
EMA 9
$63.97
Above
EMA 21
$65.27
Below
EMA 50
$67.28
Below
EMA 200
$71.68
Below
Fundamental Analysis
Valuation
67
Growth
53
Profitability
44
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
49.3×
P/B Ratio
1.44×
PEG Ratio
-1.23
Dividend Yield
0.56%
52W High
$87.64
52W Low
$61.84
Quality & Growth
ROE
444.8%
ROA
310.6%
Gross Margin
5645.0%
Operating Margin
987.1%
Revenue Growth YoY
—
Debt / Equity
0.25
AI Fundamental Assessment
P/E ratio of 49.3 (rich relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of -1.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 4.4%; Return on assets of 3.1%; Net margin of 5.9%; Gross margin of 56.5%; Current ratio of 2.09 (healthy short-term liquidity); Debt-to-equity of 0.25; Free cash flow per share is positive (3.46); Most recent quarter beat estimates by 10.5%; 2 consecutive earnings beats; EPS growth decelerating (+9.0% -> -1.2% QoQ); Average YoY EPS growth of 10.5%; Analyst estimates falling over recent quarters
Get the Full ALC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →